Rare diseases
Investigational molecules
Locations
Study of Dapagliflozin for Reducing Cardiovascular Events in Adults with High Blood Pressure
GermanyStudy of Delgocitinib Cream for Adults with Mild to Severe Palmoplantar Pustulosis: A 16-Week Treatment Trial
GermanyStudy of inavolisib, letrozole and ribociclib in untreated early-stage breast cancer patients with PIK3CA mutation
GermanyStudy of Atacicept Treatment for Patients with Multiple Autoimmune Glomerular Diseases
GermanyStudy of Rilvegostomig with Bevacizumab and Tremelimumab as First-line Treatment for Patients with Advanced Liver Cancer
GermanyStudy comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations
GermanyStudy of empagliflozin compared to placebo in patients with acute decompensated heart failure who are already taking SGLT2 inhibitors
GermanyStudy of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis
GermanyStudy of sonrotoclax plus obinutuzumab or rituximab compared to venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
GermanyStudy of trastuzumab deruxtecan with bevacizumab versus bevacizumab alone as first-line maintenance treatment for patients with HER2-expressing ovarian cancer
GermanyStudy of datopotamab deruxtecan with platinum-based therapy compared to gemcitabine with platinum-based therapy in patients with advanced urothelial cancer after prior treatment
GermanyStudy of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
